Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: a real-life study

HIGHLIGHTS

• who: Pierre-Edouard Debureaux from the Nantes Angers (CRCINA), France University of Kansas Medical Center have published the article: Prognosis of hyperviscosity syndrome in newly diagnosed multiple myeloma in modern-era therapy: A real-life study, in the Journal: (JOURNAL)
• what: The study demonstrates that HVS for NDMM patients is a rare but life-threatening complication associated with early death in older patients. The authors report here the most extensive study of NDMM patients with HVS in the modern era therapy.
• future: HVS seems associated with dismal survival in multiple myeloma but additional . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.